Hilton Worldwide Holdings Inc. (HLT) Insider Transactions
Explore official ownership filings, with every record linked to its source.
HLT · Hilton Worldwide Holdings Inc.
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-29Filed 2026-10-30 | Jacobs Kevin JOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $352.555 to $353.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $353.58 to $354.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $354.595 to $355.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $355.60 to $356.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $356.65 to $357.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $357.66 to $358.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $358.675 to $359.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F8 Reflects indirect ownership by a family trust for which the reporting person's spouse serves as trustee. F9 The option vested in three equal annual installments beginning on March 3, 2020. F10 The option vested in three equal annual installments beginning on March 3, 2021. F11 The option vested in three equal annual installments beginning on March 3, 2022. F12 The option vested in three equal annual installments beginning on March 3, 2023. F13 The option vested in three equal annual installments beginning on March 3, 2024. F14 The option vests in three equal annual installments beginning on March 3, 2025. F15 The option vests in three equal annual installments beginning on March 3, 2026. Executive Vice President and Chief Financial Officer References: | M Exercise / conversionCommon Stock · Non-derivative | 28,538A | 123.13 | Direct | Form 4 ↗0001593156-26-000010 |
| 2026-10-29Filed 2026-10-30 | Jacobs Kevin JOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $352.555 to $353.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $353.58 to $354.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $354.595 to $355.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $355.60 to $356.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $356.65 to $357.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $357.66 to $358.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $358.675 to $359.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F8 Reflects indirect ownership by a family trust for which the reporting person's spouse serves as trustee. F9 The option vested in three equal annual installments beginning on March 3, 2020. F10 The option vested in three equal annual installments beginning on March 3, 2021. F11 The option vested in three equal annual installments beginning on March 3, 2022. F12 The option vested in three equal annual installments beginning on March 3, 2023. F13 The option vested in three equal annual installments beginning on March 3, 2024. F14 The option vests in three equal annual installments beginning on March 3, 2025. F15 The option vests in three equal annual installments beginning on March 3, 2026. Executive Vice President and Chief Financial Officer References: | M Exercise / conversionCommon Stock · Non-derivative | 29,110A | 93.33 | Direct | Form 4 ↗0001593156-26-000010 |
| 2026-10-29Filed 2026-10-30 | Jacobs Kevin JOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $352.555 to $353.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $353.58 to $354.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $354.595 to $355.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $355.60 to $356.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $356.65 to $357.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $357.66 to $358.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $358.675 to $359.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F8 Reflects indirect ownership by a family trust for which the reporting person's spouse serves as trustee. F9 The option vested in three equal annual installments beginning on March 3, 2020. F10 The option vested in three equal annual installments beginning on March 3, 2021. F11 The option vested in three equal annual installments beginning on March 3, 2022. F12 The option vested in three equal annual installments beginning on March 3, 2023. F13 The option vested in three equal annual installments beginning on March 3, 2024. F14 The option vests in three equal annual installments beginning on March 3, 2025. F15 The option vests in three equal annual installments beginning on March 3, 2026. Executive Vice President and Chief Financial Officer References: | M Exercise / conversionCommon Stock · Non-derivative | 12,848A | 83.1 | Direct | Form 4 ↗0001593156-26-000010 |
| 2026-09-30Filed 2026-10-01 | Carr ChrisDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 2.895A | 0 | Direct | Form 4 ↗0001821096-26-000016 |
| 2026-09-30Filed 2026-10-01 | MAYER MARISSA ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 0.842A | 0 | Direct | Form 4 ↗0001550608-26-000021 |
| 2026-09-30Filed 2026-10-01 | Healey MelanieDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 6.374A | 0 | Direct | Form 4 ↗0001536208-26-000009 |
| 2026-09-30Filed 2026-10-01 | Mabus Raymond EDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 5.628A | 0 | Direct | Form 4 ↗0001317996-26-000010 |
| 2026-09-30Filed 2026-10-01 | STEENLAND DOUGLAS MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 9.256A | 0 | Direct | Form 4 ↗0001244673-26-000013 |
| 2026-09-30Filed 2026-10-01 | BEGLEY CHARLENE TDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 6.087A | 0 | Direct | Form 4 ↗0001233150-26-000013 |
| 2026-09-30Filed 2026-10-01 | SMITH ELIZABETH ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 8.78A | 0 | Direct | Form 4 ↗0001209033-26-000012 |
| 2026-09-30Filed 2026-10-01 | GRAY JONATHANDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 4.38A | 0 | Direct | Form 4 ↗0001208590-26-000012 |
| 2026-09-14Filed 2026-09-15 | Fuentes LauraOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of options granted in 2017 and 2018. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $309.76 to $309.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The option vested in three equal annual installments beginning on February 27, 2018. F4 The option vested in three equal annual installments beginning on March 1, 2019. Executive Vice President and Chief Human Resources Officer References: F4 | M Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,888D | 0 | Direct | Form 4 ↗0001827369-26-000007 |
| 2026-09-14Filed 2026-09-15 | Fuentes LauraOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of options granted in 2017 and 2018. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $309.76 to $309.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The option vested in three equal annual installments beginning on February 27, 2018. F4 The option vested in three equal annual installments beginning on March 1, 2019. Executive Vice President and Chief Human Resources Officer References: F3 | M Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,936D | 0 | Direct | Form 4 ↗0001827369-26-000007 |
| 2026-09-14Filed 2026-09-15 | Fuentes LauraOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of options granted in 2017 and 2018. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $309.76 to $309.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The option vested in three equal annual installments beginning on February 27, 2018. F4 The option vested in three equal annual installments beginning on March 1, 2019. Executive Vice President and Chief Human Resources Officer References: F1 | S Sale (market/private)Common Stock · Non-derivative | 2,893D | 309.825 | Direct | Form 4 ↗0001827369-26-000007 |
| 2026-09-14Filed 2026-09-15 | Fuentes LauraOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of options granted in 2017 and 2018. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $309.76 to $309.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The option vested in three equal annual installments beginning on February 27, 2018. F4 The option vested in three equal annual installments beginning on March 1, 2019. Executive Vice President and Chief Human Resources Officer References: F1, F2 | S Sale (market/private)Common Stock · Non-derivative | 4,396D | 309.803 | Direct | Form 4 ↗0001827369-26-000007 |
| 2026-09-14Filed 2026-09-15 | Fuentes LauraOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of options granted in 2017 and 2018. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $309.76 to $309.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The option vested in three equal annual installments beginning on February 27, 2018. F4 The option vested in three equal annual installments beginning on March 1, 2019. Executive Vice President and Chief Human Resources Officer References: | M Exercise / conversionCommon Stock · Non-derivative | 4,888A | 79.35 | Direct | Form 4 ↗0001827369-26-000007 |
| 2026-09-14Filed 2026-09-15 | Fuentes LauraOfficer · See RemarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of options granted in 2017 and 2018. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $309.76 to $309.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 The option vested in three equal annual installments beginning on February 27, 2018. F4 The option vested in three equal annual installments beginning on March 1, 2019. Executive Vice President and Chief Human Resources Officer References: | M Exercise / conversionCommon Stock · Non-derivative | 7,936A | 58.02 | Direct | Form 4 ↗0001827369-26-000007 |
| 2026-09-14Filed 2026-09-15 | Carr ChrisDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | S Sale (market/private)Common Stock · Non-derivative | 439D | 310.34 | Direct | Form 4 ↗0001821096-26-000014 |
| 2026-08-05Filed 2026-08-06 | Charnaux Christian H.Officer · See remarksFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares withheld by the Company for the payment of tax liability incident to vesting of restricted stock units. Executive Vice President and Chief Development Officer References: F1 | F WithholdingCommon Stock · Non-derivative | 1,854D | 324.56 | Direct | Form 4 ↗0002076715-26-000005 |
| 2026-06-30Filed 2026-07-01 | Carr ChrisDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 2.785A | 0 | Direct | Form 4 ↗0001821096-26-000012 |
| 2026-06-30Filed 2026-07-01 | MAYER MARISSA ADirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 0.81A | 0 | Direct | Form 4 ↗0001550608-26-000016 |
| 2026-06-30Filed 2026-07-01 | Healey MelanieDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 6.13A | 0 | Direct | Form 4 ↗0001536208-26-000007 |
| 2026-06-30Filed 2026-07-01 | Mabus Raymond EDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 5.413A | 0 | Direct | Form 4 ↗0001317996-26-000008 |
| 2026-06-30Filed 2026-07-01 | STEENLAND DOUGLAS MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 8.904A | 0 | Direct | Form 4 ↗0001244673-26-000011 |
| 2026-06-30Filed 2026-07-01 | BEGLEY CHARLENE TDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred share units. References: F1 | A Award / grantCommon Stock · Non-derivative | 5.855A | 0 | Direct | Form 4 ↗0001233150-26-000011 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.